Related Experiment Videos
[Thrombolysis and myocardial infarct]
1I. Medizinischen Abteilung, Allgemeinen Krankenhauses der Stadt Linz.
Insights
Thrombolytic therapy effectively opens blocked arteries in acute myocardial infarction, reducing mortality and infarct size. Percutaneous coronary intervention (PCI) is successful in most patients post-thrombolysis, improving outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
Context:
- Acute myocardial infarction (AMI) treatment involves reperfusion strategies.
- Thrombolytic therapy aims to restore blood flow in occluded coronary arteries.
- Significant residual stenosis often persists after successful thrombolysis.
Purpose:
- To evaluate the efficacy of thrombolytic therapy in AMI.
- To assess the role and outcomes of percutaneous coronary intervention (PCI) following thrombolysis.
- To determine the impact of reperfusion timing on patient mortality and infarct size.
Summary:
- Thrombolytic therapy recanalizes infarct arteries in 35-90% of AMI cases, with success varying by agent and administration route.
- Successful recanalization correlates with reduced hospital and one-year mortality and smaller infarct size, particularly when initiated early (within 3-4 hours of ischemic pain).
- Approximately 80-90% of patients have significant residual stenosis post-thrombolysis, making them candidates for PCI, which demonstrates high success rates and low complication incidence, leading to reduced reinfarction and improved left ventricular function.
Impact:
- Establishes the value of early thrombolysis in AMI for patients with short pain duration.
- Highlights PCI as an effective strategy for managing residual stenosis after thrombolysis, improving long-term cardiac function.
- Identifies the need for further research into the optimal timing of PCI post-thrombolysis.
Abstract:
Thrombolytic therapy in acute myocardial infarction is able to recanalize thrombotic occluded infarct arteries in about 35 to 90%. The results depend on the thrombolytic agent and the route of administration (i.c., i.v.). Successful recanalization causes a reduction of hospital- and one year mortality and reduction of the infarct size in a close correlation to duration of ischemic pain at the beginning of thrombolysis. Significant residual stenoses persist in about 80 to 90% after successful reperfusion. In these patients, PTCA can be performed with high success rates and with a low incidence of complications. Successful PTCA is associated with a reduction of reinfarction and further improvement of left ventricular function. Thus, the value of thrombolysis in acute myocardial infarction in patients with pain duration shorter than 3 to 4 hours is established. The value and optimal point of time for performing PTCA after thrombolysis remains to be defined.